Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $41.5 million.

  • Angiodynamics' Shares Outstanding (Weighted Average) rose 151.51% to $41.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $41.5 million, marking a year-over-year increase of 151.51%. This contributed to the annual value of $40.9 million for FY2025, which is 167.24% up from last year.
  • Per Angiodynamics' latest filing, its Shares Outstanding (Weighted Average) stood at $41.5 million for Q4 2025, which was up 151.51% from $41.2 million recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Shares Outstanding (Weighted Average) registered a high of $41.5 million during Q4 2025, and its lowest value of $38.3 million during Q2 2021.
  • In the last 5 years, Angiodynamics' Shares Outstanding (Weighted Average) had a median value of $39.7 million in 2023 and averaged $39.8 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 95.0% in 2021, then surged by 203.55% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' Shares Outstanding (Weighted Average) stood at $39.1 million in 2021, then rose by 1.12% to $39.5 million in 2022, then rose by 1.85% to $40.2 million in 2023, then increased by 1.75% to $40.9 million in 2024, then rose by 1.52% to $41.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $41.5 million for Q4 2025, versus $41.2 million for Q3 2025 and $40.9 million for Q2 2025.